Market cap
₹19 Cr
Revenue (TTM)
₹32 Cr
P/E Ratio
23.1
P/B Ratio
4
Div. Yield
0 %
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
19 | 7,888 | 31 | 20 | 20 |
Revenue (₹ Cr) |
32 | 7,128 | 13 | -3 | 562 |
Net Profit (₹ Cr) |
0.84 | 167.66 | -1.78 | -0.07 | 1.24 |
Net Margin (%) |
2.62 | 2.35 | -8.71 | 2.62 | 0.22 |
RoE (%) |
17.29 | 7.58 | -1.56 | -0.66 | 9.81 |
Price to Earnings |
23.10 | 62.90 | -- | -- | 16.28 |
Price-To-Book |
4.04 | 4.55 | 0.29 | 2.03 | 10.68 |
Income Statement (₹ Cr)
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Operating Revenue
|
31.53 | 7,127.89 | 12.55 | -2.97 | 562.10 |
|
Total Income
|
31.88 | 7,144.31 | 20.47 | -2.52 | 562.10 |
|
Total Expenditure
|
29.82 | 6,815.02 | 20.42 | -2.46 | 560.08 |
|
EBITDA
|
1.72 | 312.87 | -7.87 | -0.52 | 2.02 |
|
Depreciation
|
0.08 | 46.73 | 1.82 | 0.00 | 0.01 |
|
EBIT
|
1.63 | 266.14 | -9.69 | -0.52 | 2.01 |
|
Interest
|
0.61 | 64.29 | 0.00 | 0.00 | 0.00 |
|
Other Income
|
0.35 | 16.42 | 7.92 | 0.45 | 0.00 |
|
Exceptional Items
|
0.00 | -8.18 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
1.37 | 210.09 | -1.77 | -0.07 | 2.01 |
|
Provision for Tax
|
0.53 | 42.43 | 0.02 | 0.00 | 0.77 |
|
Profit after Tax
|
0.84 | 167.66 | -1.78 | -0.07 | 1.24 |
Liabilities (₹ Cr)
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
5.26 | 1,688.61 | 111.61 | 9.70 | 23.23 |
|
Minority Interest
|
0.00 | -42.25 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
2.86 | 260.15 | 1.14 | -0.01 | 0.00 |
|
Current Liabilities
|
6.51 | 1,587.57 | 2.71 | -0.25 | 319.67 |
|
Total Liabilities
|
-- | 2,702.52 | 125.42 | 9.79 | 0.65 |
Assets (₹ Cr)
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
4.28 | 917.21 | 67.70 | 1.27 | 0.02 |
|
Current Assets
|
10.30 | 2,508.44 | 47.02 | 7.93 | 342.89 |
|
Total Assets
|
-- | 2,702.52 | 125.42 | 9.79 | 0.65 |
|
Total Debt*
|
-- | 298.81 | 0.00 | 0.00 | 0.00 |
|
Net Current Assets
|
3.78 | 920.87 | 44.31 | 8.18 | 23.21 |
|
Contingent Liabilities
|
-- | 4.01 | -- | 1.72 | -- |
Cashflow (₹ Cr)
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | -76.87 | 5.07 | 0.22 | 0.19 |
|
Cash Flow from Investing Activities
|
-- | 219.80 | -4.98 | -0.20 | -0.18 |
|
Cash from Financing Activities
|
-- | -73.66 | -- | 0.00 | -- |
|
Net Cash Inflow / Outflow
|
-- | 69.27 | 0.09 | 0.01 | 0.01 |
Ratios
Profitability Ratios
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-- | 9.16 | -0.66 | 2.66 | 9.64 |
|
ROE (%)
|
17.29 | 7.58 | -1.56 | -0.66 | 9.81 |
|
ROA (%)
|
5.39 | 5.32 | -1.48 | -0.69 | 0.72 |
|
EBIT Margin (%)
|
5.17 | 3.73 | -77.24 | 17.33 | 0.36 |
|
Net Margin (%)
|
2.62 | 2.35 | -8.71 | 2.62 | 0.22 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 29.75 | 0.00 |
Growth Ratios
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
12.99 | 31.94 | -42.88 | -150.48 | 4,540.45 |
|
EBIT Growth (%)
|
45.11 | 67.92 | -45.53 | -266.67 | 1,710.81 |
|
Net Profit Growth (%)
|
223.85 | 43.13 | 49.20 | -109.68 | 1,288.76 |
|
EPS Growth (%)
|
106.36 | 27.72 | 49.20 | -109.68 | 1,322.31 |
|
Book Value Growth (%)
|
-- | 5.11 | 0.24 | 2.10 | 4.77 |
Valuation Ratios
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Price / Earnings
|
23.16 | 60.20 | -17.58 | -305.08 | 16.28 |
|
Price / Book Value
|
4.04 | 4.55 | 0.29 | 2.03 | 10.68 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
15.06 | 26.09 | -0.28 | -29.60 | 9.97 |
|
Market Cap (₹ Cr)
|
-- | 4,944.94 | 51.76 | 19.85 | 6.99 |
Solvency Ratios
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.53 | 0.07 | 0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
-- | 0.17 | -- | -- | -- |
|
Current Ratio
|
1.58 | 1.58 | 17.35 | -31.58 | 1.07 |
|
Quick Ratio
|
0.95 | 1.05 | 16.26 | -30.28 | 1.07 |
|
Interest Coverage
|
3.23 | 4.27 | -16.63 | -65.00 | 10.12 |
Operating Efficiency Ratios
| Maitri Enterprises | Entero Health | Medi-Caps | Pentokey Organy | Rubra Medicaments | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.47 | 17.01 | 55.16 | -39.13 | 60.08 |
|
Asset Turnover
|
2.03 | 2.26 | 0.10 | -0.31 | 3.27 |
|
Receivable days
|
-- | 51.78 | 140.45 | 482.34 | 362.19 |
|
Inventory Days
|
-- | 38.71 | 64.01 | 144.64 | 0.00 |
|
Payable days
|
-- | 24.83 | 63.40 | 44.32 | -- |
|
Cash Conversion Cycle
|
-- | 65.66 | 141.06 | 582.66 | -- |